Quest Diagnostics Incorporated (DGX) - Total Assets
Based on the latest financial reports, Quest Diagnostics Incorporated (DGX) holds total assets worth $16.67 Billion USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check DGX cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Quest Diagnostics Incorporated - Total Assets Trend (1996–2025)
This chart illustrates how Quest Diagnostics Incorporated's total assets have evolved over time, based on quarterly financial data. Explore Quest Diagnostics Incorporated (DGX) investment intensity to see how much of total assets are deployed in long-term investments.
Quest Diagnostics Incorporated - Asset Composition Analysis
Current Asset Composition (December 2025)
Quest Diagnostics Incorporated's total assets of $16.67 Billion consist of 14.7% current assets and 85.3% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $420.00 Million | 2.6% |
| Accounts Receivable | $1.41 Billion | 8.7% |
| Inventory | $189.00 Million | 1.2% |
| Property, Plant & Equipment | $2.86 Billion | 17.6% |
| Intangible Assets | $1.64 Billion | 10.1% |
| Goodwill | $8.95 Billion | 55.1% |
Asset Composition Trend (1996–2025)
This chart illustrates how Quest Diagnostics Incorporated's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Quest Diagnostics Incorporated (DGX) total market value.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Quest Diagnostics Incorporated's current assets represent 14.7% of total assets in 2025, a decrease from 36.6% in 1996.
- Cash Position: Cash and equivalents constituted 2.6% of total assets in 2025, down from 3.0% in 1996.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 65.0% of total assets, an increase from 21.0% in 1996.
- Asset Diversification: The largest asset category is goodwill at 55.1% of total assets.
Quest Diagnostics Incorporated Competitors by Total Assets
Key competitors of Quest Diagnostics Incorporated based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
SMO ClinPlus Co. Ltd.
SHE:301257
|
China | CN¥1.52 Billion |
|
Scope Fluidics SA
WAR:SCP
|
Poland | zł141.67 Million |
|
SCOPE FLUIDICS SA ZY-10
F:S84
|
Germany | €195.94 Million |
|
RHYTHM Biosciences Ltd
AU:RHY
|
Australia | AU$3.10 Million |
|
Bcal Diagnostics Ltd
AU:BDX
|
Australia | AU$7.17 Million |
|
Leveljump Healthcare Corp
V:JUMP
|
Canada | CA$21.84 Million |
|
Sonic Healthcare Ltd
AU:SHL
|
Australia | AU$17.03 Billion |
|
Australian Clinical Labs Ltd
AU:ACL
|
Australia | AU$562.50 Million |
Quest Diagnostics Incorporated - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.18 | 1.44 | 1.38 |
| Quick Ratio | 1.08 | 1.31 | 1.26 |
| Cash Ratio | 0.00 | 0.13 | 0.36 |
| Working Capital | $389.00 Million | $634.00 Million | $595.00 Million |
Quest Diagnostics Incorporated - Advanced Valuation Insights
This section examines the relationship between Quest Diagnostics Incorporated's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.84 |
| Latest Market Cap to Assets Ratio | 1.28 |
| Asset Growth Rate (YoY) | 0.4% |
| Total Assets | $16.23 Billion |
| Market Capitalization | $20.74 Billion USD |
Valuation Analysis
Above Book Valuation: The market values Quest Diagnostics Incorporated's assets above their book value (1.28x), reflecting positive investor sentiment about the company's future prospects.
Positive Asset Growth: Quest Diagnostics Incorporated's assets grew by 0.4% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Quest Diagnostics Incorporated (1996–2025)
The table below shows the annual total assets of Quest Diagnostics Incorporated from 1996 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $16.23 Billion | +0.45% |
| 2024-12-31 | $16.15 Billion | +15.20% |
| 2023-12-31 | $14.02 Billion | +9.23% |
| 2022-12-31 | $12.84 Billion | -5.69% |
| 2021-12-31 | $13.61 Billion | -2.96% |
| 2020-12-31 | $14.03 Billion | +9.21% |
| 2019-12-31 | $12.84 Billion | +16.72% |
| 2018-12-31 | $11.00 Billion | +4.76% |
| 2017-12-31 | $10.50 Billion | +3.99% |
| 2016-12-31 | $10.10 Billion | +1.39% |
| 2015-12-31 | $9.96 Billion | +0.86% |
| 2014-12-31 | $9.88 Billion | +10.38% |
| 2013-12-31 | $8.95 Billion | -3.62% |
| 2012-12-31 | $9.28 Billion | -0.32% |
| 2011-12-31 | $9.31 Billion | +9.21% |
| 2010-12-31 | $8.53 Billion | -0.42% |
| 2009-12-31 | $8.56 Billion | +1.90% |
| 2008-12-31 | $8.40 Billion | -1.89% |
| 2007-12-31 | $8.57 Billion | +51.30% |
| 2006-12-31 | $5.66 Billion | +6.70% |
| 2005-12-31 | $5.31 Billion | +26.22% |
| 2004-12-31 | $4.20 Billion | -2.27% |
| 2003-12-31 | $4.30 Billion | +29.40% |
| 2002-12-31 | $3.32 Billion | +13.43% |
| 2001-12-31 | $2.93 Billion | +2.30% |
| 2000-12-31 | $2.86 Billion | -0.49% |
| 1999-12-31 | $2.88 Billion | +111.62% |
| 1998-12-31 | $1.36 Billion | -2.91% |
| 1997-12-31 | $1.40 Billion | +0.42% |
| 1996-12-31 | $1.40 Billion | -- |
About Quest Diagnostics Incorporated
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides services under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagn… Read more